Advertisement
Original communication| Volume 92, ISSUE 1, P52-60, July 1982

Prostaglandin mediation of unstable hemodynamics during lung perfusion

  • Gene A. Grindlinger
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital and Harvard University School of Medicine, Boston, Mass., USA

    From the Department of Biochemistry, Brandeis University, Boston, Mass., USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • Takayoshi Utsunomiya
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital and Harvard University School of Medicine, Boston, Mass., USA

    From the Department of Biochemistry, Brandeis University, Boston, Mass., USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • Armando Vegas
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital and Harvard University School of Medicine, Boston, Mass., USA

    From the Department of Biochemistry, Brandeis University, Boston, Mass., USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • Lawrence L. Levine
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital and Harvard University School of Medicine, Boston, Mass., USA

    From the Department of Biochemistry, Brandeis University, Boston, Mass., USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • David Shepro
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital and Harvard University School of Medicine, Boston, Mass., USA

    From the Department of Biochemistry, Brandeis University, Boston, Mass., USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
  • Herbert B. Hechtman
    Correspondence
    Reprint requests: Herbert B. Hechtman, M.D., Brigham and Women's Hospital. 75 Francis St., Boston, MA 02115.
    Affiliations
    From the Department of Surgery, Brigham and Women's Hospital and Harvard University School of Medicine, Boston, Mass., USA

    From the Department of Biochemistry, Brandeis University, Boston, Mass., USA

    From the Biological Science Center, Boston University, Boston, Mass., USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Positive end-expiratory pressure (PEEP) leads to a fall in both mean arterial blood pressure (MAP) and cardiac output (CO). This study tests the hypothesis that humoral factors, particularly prostanoids, are important mediators of these events. A support dog was used for ex vivo perfusion of an isolated left lung lobe (LLL) at a fixed flow. In group I (n = 10) an isolated, isovolumetrically contracting dog heart was placed in circuit between the support dog and LLL. Indomethacin (5 mg/kg) was used to pretreat the support dogs and LLL donors of group II (n = 9); support dogs of group III (n = 5); and LLL donors of group IV (n = 4). This cyclooxygenase inhibitor was not used for groups I or V (n = 14). The last two groups were similar except that a heart was not included in the circuit of group V. In group V lobe perfusion during simple inspiratory mechanical ventilation led to decreases in support dog MAP from 141 ± 3 to 118 ± 15 mm Hg (P < 0.01) and CO from 4.0 ± 0.9 to 2.8 ± 0.8 L/mim (P < 0.01). Application of PEEP further reduced MAP and CO (P < 0.01). In the perfused isolated hearts of group I, Starling curves were shifted downward during PEEP at five of six left ventricular balloon volumes tested. In groups II and III MAP and CO were unchanged with mechanical ventilation or PEEP and were higher than groups I or V (P < 0.05). Radioimmunoassay of the stable degradation products of prostacyclin and thromboxane (Tx) A2 demonstrated low concentrations of these prostanoids in support dogs of group III as compared with group V (P < 0.05). Blocking the LLL donor dog (group IV) produced hemodynamic results and prostanoid concentrations intermediate between groups I and V. The results show that mechanical ventilation and PEEP can cause a circulating agent (s) to be released that results in a decline in MAP and CO. This is prevented with indomethacin.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Armstrong JM
        • Chapple D
        • Dusting GJ
        • Hughes R
        • Moncada S
        • Vane JR
        Cardiovascular actions of prostacyclin (PGI2) in chloralose anesthetized dogs.
        Br J Pharmacol. 1977; 61: 136P
        • Bakhle YS
        • Vane JR
        Pharmacokinetic function of the pulmonary circulation.
        Physiol Rev. 1974; 54: 1007-1045
        • Berry EM
        • Edmunds JF
        • Wyllie JH
        Release of prostaglandin E2 and unidentified factors from ventilated lungs.
        Br J Surg. 1971; 58: 189-192
        • Cournand A
        • Motley ML
        • Werko L
        • Richards DW
        Physiological studies on the effect of intermittent positive-pressure breathing on cardiac output in man.
        Am J Physiol. 1948; 152: 162-174
        • Dunham B
        • Grindlinger GA
        • Utsunomiya T
        • Krausz MM
        • Hechtman HB
        • Shepro D
        Role of prostaglandins in positive end-expiratory pressure induced negative inotropism.
        Am J Physiol. 1981; 241: H783-H788
        • Elkins RC
        • Peyton MD
        • Hinshaw LB
        • Greenfield NJ
        Clinical hemodynamic and respiratory responses to graded positive end-expiratory pressure.
        in: Surg Forum. 25. 1974: 262-269
        • Fitzpatrick TM
        • Alter I
        • Corey EJ
        • Ramwell PW
        • Rose JC
        • Kot PA
        Cardiovascular responses to PGI2 (prostacyclin) in the dog.
        Circ Res. 1978; 42: 192-194
        • Friedman LS
        • Fitzpatrick TM
        • Bloom MF
        • Ramwell PW
        • Rose JC
        • Kot PA
        Cardiovascular and pulmonary effects of thromboxane B2 in the dog.
        Circ Res. 1979; 44: 748-751
        • Grindlinger GA
        • Manny J
        • Justice R
        • Dunham B
        • Shepro D
        • Hechtman HB
        Presence of negative inotropic agents in canine plasma during positive end-expiratory pressure.
        Circ Res. 1979; 45: 460-467
        • Hammerschmidt DE
        • White JG
        • Craddock PR
        • Jacob HS
        Corticosteroids inhibit complement-induced granulocyte aggregation.
        J Clin Invest. 1979; 63: 798-803
        • Hechtman HB
        • Krausz MM
        • Utsunomiya T
        • Levine L
        • Shepro D
        Cardiovascular function following surgical stimulation and pulmonary prostacyclin synthesis.
        Thromb Haemost. 1981; 46: 44
        • Hyman AL
        • Kadowitz PJ
        Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
        Circ Res. 1979; 45: 404-409
        • Karmazyn M
        • Dhalla NS
        Thromboxane B2: A cardiodepressant of isolated rat hearts and inhibitor of sarcolemma Na+-K+ stimulated ATPase activity.
        Prostaglandins Med. 1979; 3: 81-93
      1. Krausz MM, Utsunomiya T, Levine L, Dunham B, Shepro D, Hechtman HB: Adverse effects of prostacyclin used to perfuse isolated lung lobes. Am J Physiol (in press)

        • Levine L
        • Alam I
        • Langone J
        The use of immobilized ligands and 125I protein A for immunoassays of thromboxane B2, prostaglandin D2, 13,14-dihydro-prostaglandin E2, 5,6-dihy-dro-prostaglandin I2, 6-keto-prostaglandin F, 15-hydroxy-9α, 11α(epoxymethano)prosta-5, 13-dienoic acid and 15-hydroxy-11α, 9α(epoxymethano)prosta-5, 13-dienoic acid.
        Prostaglandins Med. 1979; 2: 177-189
        • Liebrnan PR
        • Patten MT
        • Manny J
        • Shepro D
        • Hechtman HB
        The mechanism of depressed cardiac output on positive end-expiratory pressure (PEEP).
        Surgery. 1978; 83: 594-598
        • Manny J
        • Grindlinger GA
        • Mathe AA
        • Hechtman HB
        Positive end-expiratory pressure, lung stretch, and decreased myocardial contractility.
        Surgery. 1978; 84: 127-133
        • Manny J
        • Justice R
        • Hechtman HB
        Left ventricular filling pressure as a determinant of subendocardial blood flow.
        Ann Thorae Surg. 1979; 27: 451-459
        • Manny J
        • Patten MT
        • Liebman PR
        • Hechtman HB
        The association of lung distention, PEEP and biventricular failure.
        Ann Surg. 1978; 187: 151-157
        • Patten MT
        • Liebman PR
        • Manny J
        • Shepro D
        • Hechtman HB
        Humorally mediated alterations of cardiac performance as a consequence of positive end-expiratory pressure.
        Surgery. 1978; 84: 201-205
        • Qvist J
        • Pontoppidan H
        • Wilson R
        • Lowenstein E
        • Laver MB
        Hemodynamic responses to mechanical ventilation with PEEP.
        Anesthesiology. 1975; 42: 45-55
        • Romero J
        • Dunlap C
        • Strong C
        The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system.
        J Clin Invest. 1976; 58: 282-288
        • Said SI
        • Kitamura S
        • Vreim C
        Prostaglandins: Release from the lungs during mechanical ventilation at large tidal volumes.
        J Clin Invest. 1972; 51: 83a
        • Vegas AM
        • Grindlinger GA
        • McLoughlin GA
        • Hechtman HB
        Control of pulmonary fibrinolytic activity by prostaglandins.
        in: Surg Forum. 30. 1979: 180-181